DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Omni Rancho Las Palmas Resort & Spa

2018年3月19日 (月) 午後 1:00 - 2018年3月21日 (水) 午後 4:00

41000 Bob Hope Drive, Rancho Mirage, CA 92270

Medical Affairs and Scientific Communications Forum

Medical Communication, MSL, and Medical Writing.

Session 9 Track 2A: Scientific Communication Strategy

Session Chair(s)

David B. Clemow, PhD

David B. Clemow, PhD

Advisor, Scientific Communications Information Strategy

Eli Lilly and Company, United States

This session will provide insights and best practices for creating and organizing consistent messaging across regulatory submission and publication documents, with a focus on mapping clinical trial data outputs to key messages and downstream disclosure documents. The role of scientific communications (medical writing) in medical key message development, knowledge management, and dissemination will be discussed, with suggestions for process integration with other medical functions to aid with synergy. These topics will also be reviewed more holistically regarding the overall role of medical writers involvement in scientific communications strategy, based upon insights from the DIA Medical Writing Competency Model.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Apply and map clinical trial data outputs and related key messages from target profile through regulatory submission documents and publication disclosures
  • Define the role of scientific communications in medical key message development, knowledge management, and dissemination related to cross-functional partners
  • Explain the involvement of the medical writer role in scientific communications strategy
  • Speaker(s)

    David  Brown, MA, MSc

    Submission Communication Strategy Document to Drive Consistent Messaging in CTD Dossiers

    David Brown, MA, MSc

    AstraZeneca Pharmaceuticals, United States

    Therapy Area Leader, Medical Communications

    David B. Clemow, PhD

    Medical and Scientific Key Message Development, Knowledge Management, and Dissemination

    David B. Clemow, PhD

    Eli Lilly and Company, United States

    Advisor, Scientific Communications Information Strategy

    Michael  Bourque, MS

    Medical Writing Leadership in Scientific Communications Strategy

    Michael Bourque, MS

    Synchrogenix, a Certara Company, United States

    Director of Global Submissions

    最新情報や機会を逃さないで

    DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。